Z-0722-2017 Class III Terminated

Recalled by OraSure Technologies, Inc. — Bethlehem, PA

FDA device recall Z-0722-2017 was initiated by OraSure Technologies, Inc. on Nov 10, 2016 and is designated Class III. Reason for recall: Shipping error. Cocaine metabolite Microplate distributed instead of Barbiturate Microplate due to incorrect selection of Microplate during manufacturing. The recall status is terminated (terminated Apr 17, 2017). Affected quantity: 4 kits.

Recall details

Product Type
Devices
Report Date
Dec 14, 2016
Initiation Date
Nov 10, 2016
Termination Date
Apr 17, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4 kits

Product description

Barbiturates Intercept Micro-Plate EIA (enzyme immunoassay, barbiturate) Product is intended for use by clinical laboratories in the qualitative determination of barbiturates in oral fluids.

Reason for recall

Shipping error. Cocaine metabolite Microplate distributed instead of Barbiturate Microplate due to incorrect selection of Microplate during manufacturing.

Distribution pattern

Distributed to KS, and VA

Code information

Lot # 6654085

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0722-2017
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0722-2017. Report a data issue: hello@regdatalab.com.